You are here: Industry Insights > Antibiotic

News List

Drug Apocalypse of the Future: Artificial Intelligence Discovers New Antibiotics, Disrupting Traditional Innovations Big Cat of Medical Field
March 11, 2024
At present, the use of artificial intelligence to participate in the discovery and design of new drugs has become a hot track for new drug research and development.
Sulfamethoxazole API Price and Manufacturers in China PharmaSources.com
July 28, 2021
Sulfamethoxazole is an antibiotic used to treat bacterial infections of the skin, urinary tract infections, bronchitis, Salmonella infections, children acute otitis media, and meningitis, and prostatitis.
Ampicillin Sodium APIManufacturers In China PharmaSources
June 22, 2021
Ampicillin is an antibiotic. It is one of the most widely used drugs in the world to treat bacterial infections. First discovered in 1958, it started to be used commercially in 1961.
What’s the Market Size for Chloramphenicol Powder? PharmaSources
June 22, 2021
Chloramphenicol is an antibiotic that works against a range of bacterial infections. It is available in various forms, including eye drops for conjunctivitis.
Where can you buy Cephalexin Monohydrate API Powder in bulk? PharmaSources
June 04, 2021
Cephalexin is an antibacterial drug of the cephalosporin class.
First Antibiotics Used by Doctors, Penicillin API manufacturers in China PharmaSources
June 04, 2021
Penicillin is an antibiotic, belonging to the beta-lactamase class of drugs.
Everything You Need to Know About Ceftiofur and Where to Buy in Bulk Quantities PharmaSources
May 17, 2021
Ceftiofur is a broad-spectrum cephalosporin antibiotic with a significant action on gram-positive and gram-negative bacteria, such as beta-lactamase-producing strains.
The key to a powerful antibiotic's formation now clear WorldPharmaNews
February 07, 2022
A powerful class of antibiotics called carbapenems can circumvent antibiotic resistance thanks to a particular chain of atoms in their structure. Now, a team of researchers from Penn State and Johns Hopkins University...
Press Release New resistance-busting antibiotic combination could extend the use of ‘last-resort’ antibiotics FirstWordPharma
December 14, 2021
Scientists have discovered a new potential treatment that has the ability to reverse antibiotic resistance in bacteria that cause conditions such as sepsis, pneumonia, and urinary tract infections.
CARB-X Funds the 3rd Round of Debiopharm's Targeted Antibiotic Program to Combat Resistant N. gonorrhoeae Infections prnasia
October 19, 2021
Debiopharm (www.debiopharm.com), a Swiss-based global biopharmaceutical company announced today having been awarded the third phase funding to advance the development of its antibiotic program, Debio 1453...

Previous page 1 2 3 4 5 6 7 8 9 10 11 12 Next page